Private Management Group
AZR icon

Private Management Group’s Azora Therapeutics, Inc. Common Stock AZR Stock Holding History

Private Management Group’s Portfolio AZR Stock Details AZR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-400
Closed -$2.2K – 312
2025
Q4 		$2.2K Hold
400
– – ﹤0.01% 310
2025
Q3 		$3.54K Buy
+400
New +$3.9K ﹤0.01% 295

Other funds holding AZR

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Manchester Capital Management
Manchester Capital Management Manchester, Vermont $736M AUM 20.83% 1-Year Est. Return
Tower Research Capital (TRC)
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Raffa Wealth Management
Raffa Wealth Management Washington, District of Columbia $793M AUM 13.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SBI Securities
SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return

Private Management Group's AZR Position: Q1 2026 in Review

Private Management Group sold out of Azora Therapeutics, Inc. Common Stock (AZR) in Q1 2026, closing a stake of 400 shares — an estimated $2.2K sold.

Private Management Group first reported a position in AZR in Q3 2025 and held it in 2 quarters. The position peaked at $3.54K in Q3 2025. 15 funds tracked by Wall St. Rank hold AZR as of Q1 2026.

  • Private Management Group reported no remaining Azora Therapeutics, Inc. Common Stock position as of Q1 2026 after selling out during the quarter.
  • Private Management Group sold 400 Azora Therapeutics, Inc. Common Stock shares in Q1 2026, an estimated $2.2K.
  • Private Management Group first reported a position in Azora Therapeutics, Inc. Common Stock in Q3 2025 and held it in 2 quarters.
  • Private Management Group's Azora Therapeutics, Inc. Common Stock position peaked at $3.54K in Q3 2025.
  • 15 funds tracked by Wall St. Rank held Azora Therapeutics, Inc. Common Stock as of Q1 2026.

Based on Private Management Group's 13F filing for Q1 2026, filed 8 May 2026.